Kumar Sharma, Guanshi Zhang, Jens Hansen, Petter Bjornstad, Hak Joo Lee, Rajasree Menon, Leila Hejazi, Jian-Jun Liu, Anthony Franzone, Helen C Looker, Byeong Yeob Choi, Roman Fernandez, Manjeri A Venkatachalam, Luxcia Kugathasan, Vikas S Sridhar, Loki Natarajan, Jing Zhang, Varun S Sharma, Brian Kwan, Sushrut S Waikar, Jonathan Himmelfarb, Katherine R Tuttle, Bryan Kestenbaum, Tobias Fuhrer, Harold I Feldman, Ian H de Boer, Fabio C Tucci, John Sedor, Hiddo Lambers Heerspink, Jennifer Schaub, Edgar A Otto, Jeffrey B Hodgin, Matthias Kretzler, Christopher R Anderton, Theodore Alexandrov, David Cherney, Su Chi Lim, Robert G Nelson, Jonathan Gelfond, Ravi Iyengar
Diabetic kidney disease (DKD) can lead to end-stage kidney disease (ESKD) and mortality; however, few mechanistic biomarkers are available for high-risk patients, especially those without macroalbuminuria. Urine from participants with diabetes from the Chronic Renal Insufficiency Cohort (CRIC) study, the Singapore Study of Macro-angiopathy and Micro-vascular Reactivity in Type 2 Diabetes (SMART2D), and the American Indian Study determined whether urine adenine/creatinine ratio (UAdCR) could be a mechanistic biomarker for ESKD...
October 16, 2023: Journal of Clinical Investigation